Literature DB >> 15563009

Diagnosis of tuberous sclerosis complex.

E Steve Roach1, Steven P Sparagana.   

Abstract

Tuberous sclerosis complex is a dominantly inherited disorder affecting multiple organs; because of its phenotypic variability, the diagnosis of tuberous sclerosis complex can be difficult in the young or in individuals with subtle findings. Recently revised consensus diagnostic criteria for tuberous sclerosis complex reflect an improved understanding of its clinical manifestations and its genetic and molecular mechanisms. The diagnostic criteria are based on the premise that there are probably no truly pathognomonic clinical signs for tuberous sclerosis complex; signs that were once regarded as specific occur as isolated findings in individuals with no other clinical or genetic evidence of tuberous sclerosis complex. Consequently, the revised criteria require tuberous sclerosis complex-associated lesions of two or more organ systems or at least two dissimilar lesions of the same organ to confirm the diagnosis. The addition of DNA testing complements clinical diagnosis and allows more precise genetic counseling and, in some individuals, prenatal diagnosis. Nevertheless, the 15% false-negative rate for DNA testing and the occurrence of germline mosaicism in about 2% of individuals with tuberous sclerosis complex make it difficult to exclude the diagnosis of tuberous sclerosis complex in family members.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563009     DOI: 10.1177/08830738040190090301

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  47 in total

Review 1.  Genetics of hereditary neurological disorders in children.

Authors:  Yue Huang; Sui Yu; Zhanhe Wu; Beisha Tang
Journal:  Transl Pediatr       Date:  2014-04

2.  Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.

Authors:  Hope Northrup; Darcy A Krueger
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

3.  MRI findings reveal three different types of tubers in patients with tuberous sclerosis complex.

Authors:  Anne Gallagher; Ellen P Grant; Neel Madan; Delma Y Jarrett; David A Lyczkowski; Elizabeth A Thiele
Journal:  J Neurol       Date:  2010-03-30       Impact factor: 4.849

4.  Frequency of undiagnosed cystic lung disease in patients with sporadic renal angiomyolipomas.

Authors:  Jay H Ryu; Thomas E Hartman; Vicente E Torres; Paul A Decker
Journal:  Chest       Date:  2011-07-07       Impact factor: 9.410

5.  Long-term outcomes of epilepsy surgery in tuberous sclerosis complex.

Authors:  Shuli Liang; Juncheng Zhang; Zhixian Yang; Shaohui Zhang; Zhiqiang Cui; Jianfei Cui; Jiwu Zhang; Na Liu; Ping Ding
Journal:  J Neurol       Date:  2017-05-17       Impact factor: 4.849

6.  Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex.

Authors:  Àlex Rovira; María Luz Ruiz-Falcó; Elena García-Esparza; Eduardo López-Laso; Alfons Macaya; Ignacio Málaga; Élida Vázquez; Josefina Vicente
Journal:  J Neurooncol       Date:  2014-04-27       Impact factor: 4.130

7.  Polycystic kidney disease and chronic renal failure in tuberous sclerosis.

Authors:  Mona Dhakal; O P Dhakal; Dhurba Bhandari
Journal:  BMJ Case Rep       Date:  2013-10-02

Review 8.  Hereditary syndromes predisposing to endocrine tumors and their skin manifestations.

Authors:  Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

9.  Renal angiomyolipomas in tuberous sclerosis--rare but potentially life-threatening lesions.

Authors:  Adnan Azim; Govindaraj Rajkumar
Journal:  BMJ Case Rep       Date:  2012-12-14

10.  Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients.

Authors:  William E Wu; Ivan I Kirov; Assaf Tal; James S Babb; Sarah Milla; Joseph Oved; Howard L Weiner; Orrin Devinsky; Oded Gonen
Journal:  Epilepsy Behav       Date:  2013-03-22       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.